tiprankstipranks
pc:umoja

Umoja Biopharma

1150 Eastlake Ave E Suite 400 Seattle, Washington 98109, US
Therapeutics
Umoja Biopharma develops off-the-shelf, pluripotent stem cell–derived immune effector cell therapies for oncology. The company combines iPSC engineering, genetic modification, and scalable manufacturing to produce standardized allogeneic cell therapy products and support clinical development.

Leadership & Board

Current Number of Employees224
Current LinkedIn Followers22,869

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$100M
Total Amount Raised$100M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$100M
Latest Funding Amount$100M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Feb 14, 2025
Series C
$100.00M
―

Investors

Investor Name
Funding Round
Double Point Ventures
Series C
DCVC Bio
Series C

Related News and Analysis

Virta Health Expands Leadership Program to Support Scalable Growth

Virta Health Expands Leadership Program to Support Scalable Growth

According to a recent LinkedIn post from Virta Health, the company is expanding its Compass Leadership Program to...
1d ago
VIRTA
AssemblyAI Debuts Voice Agent API Aimed at Streamlined AI Call Handling

AssemblyAI Debuts Voice Agent API Aimed at Streamlined AI Call Handling

According to a recent LinkedIn post from AssemblyAI, the company is highlighting the launch of its Voice Agent...
1d ago
ASS64
Plexāā Targets Breast Surgery Market Exposure at ASBrS 2026

Plexāā Targets Breast Surgery Market Exposure at ASBrS 2026

According to a recent LinkedIn post from Plexāā | Creators of BLOOM⁴³, the company plans to attend the...
1d ago
PLEXC
Design Award and Clinical Data Spotlight BLOOM⁴³ Surgical Care Platform

Design Award and Clinical Data Spotlight BLOOM⁴³ Surgical Care Platform

According to a recent LinkedIn post from Plexāā | Creators of BLOOM⁴³, the company has been featured in...
1d ago
PLEXC
Tines Highlights Partner-Led Growth and Expanded Channel Ecosystem in FY2026

Tines Highlights Partner-Led Growth and Expanded Channel Ecosystem in FY2026

According to a recent LinkedIn post from Tines, the security automation company is emphasizing strong momentum in its...
1d ago
TINES
KROMATID Highlights Advanced Cytogenetic Platform for Cell and Gene Therapy Workflows

KROMATID Highlights Advanced Cytogenetic Platform for Cell and Gene Therapy Workflows

According to a recent LinkedIn post from KROMATID, the company’s research team is showcasing data at the ISCT...
1d ago
KROMA
Techstars Highlights Space Accelerator Tied to U.S. Space Force and NASA JPL

Techstars Highlights Space Accelerator Tied to U.S. Space Force and NASA JPL

According to a recent LinkedIn post from Techstars, the firm is promoting its Techstars Space Accelerator, which focuses...
1d ago
TECHS
C2FO Emphasizes AI Use Cases in Treasury and Liquidity at Working Capital Forum Americas

C2FO Emphasizes AI Use Cases in Treasury and Liquidity at Working Capital Forum Americas

According to a recent LinkedIn post from C2FO, the company plans to participate in the Working Capital Forum...
1d ago
CFOXX
Tines Highlights Automation-First Strategy for Mission-Critical Workflows

Tines Highlights Automation-First Strategy for Mission-Critical Workflows

According to a recent LinkedIn post from Tines, the company is drawing attention to a profile by venture...
1d ago
TINES
Deel Highlights Engagement With Early-Stage Founders at The Pitch London

Deel Highlights Engagement With Early-Stage Founders at The Pitch London

A LinkedIn post from Deel highlights the company’s involvement with The Pitch London, an event sponsored by J.P....
1d ago
DEELX